Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Harvard Scientific (HVSF)Hot$$- male impotency medicine -- Ignore unavailable to you. Want to Upgrade?

To: BAD BILLY who wrote (2783)	1/18/1998 1:12:00 PM
From: RAP	Read Replies (1) \| Respond to of 3906

Dilution soon to follow! According to the deal the following dilution will occur: 1. $5,000,000 at 5/16 (0.3164) yielding 15,802,781 shares 2. $2,500,000 at 5/8 (0.6324) yeilding 3,953,194 shares 3. $2,500,000 at 1 1/4 (1.265) yielding 1,976,284 shares The funding for $10,000,000 shares will increase the number of shares by 21,732,259!!!!! I do not believe $10,000,000 will be sufficent to fund this company through phase III. Also it looks like only a small part of the $10 million is committed. What is interesting is Waite and See, I believe, are using the proceeds from selling HVSF between $9 and $3 to fund the investment. If this is true, us shareholders who lost money have actually funded yhishis new investment. This also means that Waite and See have found a machine that just prints money for them, HVSF. The money comes from suckers who invest in a company with no revenue, a handful of employees, and army of promoters and investor relations resources, and a dream. As far as a new partner, this company announced in a press release that they were negotiating with more than one partner over a year ago. The press release stated that a contract would be signed in 60 days. We never heard about a partner since. Just because the stock goes up, this does not mean the fundamentals have changed!!!! RAP, a former sucker